Published in Breast Cancer Res Treat on February 28, 2014
Lifestyle changes for prevention of breast cancer. Electron Physician (2014) 0.84
Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf (2014) 0.82
Cardiac glycosides use and the risk of lung cancer: a nested case-control study. BMC Cancer (2014) 0.75
Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies. PLoS One (2017) 0.75
Digoxin reduces the mutagenic effects of Mitomycin C in human and rodent cell lines. Cytotechnology (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet (2003) 18.24
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol (1995) 9.27
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A (2008) 4.79
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Gynecomastia. N Engl J Med (1993) 3.75
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst (2011) 3.73
Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol (2000) 3.24
Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.22
Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov (2008) 2.80
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77
Cardiac glycosides as novel cancer therapeutic agents. Mol Interv (2008) 2.70
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol (1999) 2.59
The protective role of pregnancy in breast cancer. Breast Cancer Res (2005) 1.95
Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst (2008) 1.90
Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol (2008) 1.58
Is digitalis a therapy for breast carcinoma? Oncol Rep (1999) 1.58
Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol (1980) 1.53
Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer (2001) 1.50
Risk factors for male breast cancer--a case-control study from Scandinavia. Acta Oncol (2001) 1.40
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. Mol Pharmacol (2004) 1.36
The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci (2007) 1.28
Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res (2009) 1.27
Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am (2008) 1.26
Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat (2005) 1.21
Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer (1990) 1.18
Changes in sodium pump expression dictate the effects of ouabain on cell growth. J Biol Chem (2009) 1.16
Cardiac glycosides and breast cancer. Lancet (1979) 1.16
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res (2008) 1.07
Digoxin use and the risk of breast cancer in women. J Clin Oncol (2011) 1.07
Hormone replacement therapy and the risk of breast cancer. Eur J Cancer (2008) 1.05
Pleiotropic effects of cardioactive glycosides. Curr Med Chem (2011) 1.02
Mammographic screening and risk factors for breast cancer. Am J Epidemiol (2009) 0.99
Cardiac glycosides in cancer research and cancer therapy. Acta Pol Pharm (2007) 0.94
Use of common medications and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 0.94
Na,K-ATPase as a signal transducer. Ann N Y Acad Sci (2003) 0.92
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications. Clin Cancer Res (2012) 0.92
The evolving role of estrogen therapy in prostate cancer. Clin Prostate Cancer (2002) 0.90
Interaction of digitalis and spironolactone with human sex steroid receptors. J Clin Endocrinol Metab (1978) 0.86
Use of the confidence interval function. Epidemiology (1990) 0.85
Breast cancer screening update. Am Fam Physician (2013) 0.84
Digoxin and hormone receptors. Lancet (1979) 0.84
Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix. Int J Cancer (2011) 0.82
Digitalis and breast cancer. Lancet (1984) 0.81
Effect of digoxin on DNA synthesis and cell viability in human breast tumour tissue in organ culture. Chemotherapy (1983) 0.76
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell (2012) 2.94
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92
Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56
Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol (2009) 2.55
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29
Night shift work and the risk of endometrial cancer. Cancer Res (2007) 2.28
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 2.23
Relation of food cost to healthfulness of diet among US women. Am J Clin Nutr (2010) 2.19
Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension (2002) 2.16
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst (2002) 2.16
Anthropometric measures and their relation to incident primary open-angle glaucoma. Ophthalmology (2010) 2.15
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2005) 2.15
Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med (2010) 2.15
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11
Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Fish consumption and risk of stroke in men. JAMA (2002) 2.08
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03
Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care (2003) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2007) 2.01
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer (2007) 2.01
Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol (2009) 1.99
Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med (2012) 1.98
Cigarette smoking and the incidence of breast cancer. Arch Intern Med (2011) 1.97
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95
Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ (2003) 1.94
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev (2002) 1.91
Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med (2004) 1.91
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.90
Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst (2008) 1.90
Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr (2004) 1.88
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
Mediterranean diet and cognitive function in older age. Epidemiology (2013) 1.85
Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst (2005) 1.84
Oral health and peripheral arterial disease. Circulation (2003) 1.83